- 询价
- Nebulabio
- 中国
- NBL-292157
- 2026年01月06日
企业认证
相关产品推荐更多 >
![磺胺二甲基嘧啶, HSA [抗原]](https://img1.dxycdn.com/p/s14/2025/0919/675/8657573427686398691.jpg!wh200)
万千商家帮你免费找货
0 人在求购买到急需产品
- 详细信息
- 文献和实验
- 技术资料
- 保质期：
见COA
- 库存：
大量
- 供应商：
北京辰辉创聚生物技术有限公司
- 规格：
100ug; 500ug; 1mg; Bulk
| 产品信息
品名：NebuSelect™ Recombinant Influenza B virus (Flu B) NP/Nucleoprotein Protein, 1-560aa, His-tag
中文名称：重组Influenza B virus (Flu B) NP/Nucleoprotein 蛋白
别名：Nucleoprotein, Nucleocapsid protein, Protein N, NP
货号：NBL-292157
品牌：Nebulabio
规格：100UG；1MG；Bulk
| 产品描述
NebuSelect™ Recombinant Influenza B virus (Flu B) NP/Nucleoprotein Protein, His-tag (Cat# NBL-292157) is expressed in E. coli. This recombinant protein is of high purity, verified to be greater than 90% by SDS-PAGE. Endotoxin levels are less than 1 EU/µg, as determined by the LAL (Limulus Amebocyte Lysate) assay.
| 产品属性
Species:Influenza B virus
Expression System:E. coli
Molecular Weight:64 kDa
Target Name:NP/Nucleoprotein
Purity:>90% by SDS-PAGE.
Formulation:See COA
Endotoxin:＜1 EU/ug(LAL Method)
Storage:4°C for short term. -20°C for long term.
For Research Use Only!
To get more information, please contact us freely.
风险提示：丁香通仅作为第三方平台，为商家信息发布提供平台空间。用户咨询产品时请注意保护个人信息及财产安全，合理判断，谨慎选购商品，商家和用户对交易行为负责。对于医疗器械类产品，请先查证核实企业经营资质和医疗器械产品注册证情况。
文献和实验PCR for the Detection of Influenza Viruses in Clinical Material
Influenza viruses are segmented, negative-stranded RNA viruses belonging to the family Orthomyxoviridae . They are classified into influenza A, B, and C on the basis of different epitopes on the nucleoprotein (NP) and matrix proteins (M
and can be isolated and cloned by recombinant DNA techniques. This hygromycin B-resistance gene is particularly useful for identification or selection of recombinant clones in a variety of cell types. Hygromycin B penetrates cells that have been permeabilized by virus
Construction of Recombinant Vaccinia Virus Expressing HCV Genes
Hepatitis C virus (HCV) remains the leading cause of non-A, non-B hepatitis, and a major indicator for orthotopic liver transplantation. To date, finding a cure or even a commonly effective therapy for infection with HCV has proven
技术资料暂无技术资料 索取技术资料
